CerSci Therapeutics: San Diego biotech acquires Texas startup and its pain relief drugs for $52M
Acadia pharmaceuticals says the deal is a natural fit for a local biotech focused on nervous system disorders
Read full article »
CerSci is a biopharmaceutical company that provides non-opioid analgesic products for the treatment of sciatica and neuropathic pain syndromes.
Read more